Moreover, Tregs comprise 8–20% of the CD4+ T cell population in normal adult skin, but they account for approximately 45% of CD4+ cells in the BCC TME, demonstrating a two-fold increase that mediates the immunosuppressed environment to favor skin cancer progression [25]. The gene discussed is CD4; the disease is skin neoplasm.